Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15589582 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
Conditions: Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: aminocamptothecin colloidal dispersion

Indicates status has not been verified in more than two years